Adjuvant and neoadjuvant trastuzumab in combination with vinorelbine for HER2+ breast cancer.
Khashayar Esfahani
No relevant relationships to disclose
Cristiano Ferrario
No relevant relationships to disclose
Philippe Le
No relevant relationships to disclose
Lawrence C. Panasci
No relevant relationships to disclose